Ann: Annual Report to shareholders , page-5

Please don't get too enthusiastic about DS. We can be screwed by DS just as easy as GSK or any other big pharma. We are in a mutually convenient lani partnership with DS for the next 15 years or so, but the level does not have to be raised and we're not permanently committed. I suspect DS is better than GSK, but we just have to get the best lani deal possible.

Check out the BioProspect (BPO) HotCopper forum to find a board that partnered but did not take proper care of business.